BMPR2 and pulmonary arterial hypertension: Genotype–phenotype correlation analysis have shown significant clinical phenotypic differences between Bmpr2 mutation carriers and non-carriers [4–6, 33], highlighting the type of the mutation which affects clinical phenotype among the PAH patients with Bmpr2 mutation.